GUYANA’S healthcare and pharmaceutical sectors are poised for further expansion as a Kuwaiti investment company has signalled strong interest in entering the local market, reflecting growing international confidence in the country’s non-oil economic potential.
Representatives of Kuwait-based Royal Group on Monday met with Chief Investment Officer and Head of the Guyana Office for Investment (GO-Invest), Peter Ramsaroop, MP, to explore opportunities for investment in healthcare and pharmaceutical development. The engagement comes ahead of the annual Guyana Energy Conference and Supply Chain Expo, highlighting how global attention generated by the country’s booming energy industry is increasingly spilling over into strategic sectors beyond oil and gas.
Government officials say the expression of interest aligns with ongoing national efforts to strengthen healthcare capacity through the establishment of biomedical hubs, modernisation of drug supply and distribution systems, and reforms to regulatory frameworks governing pharmaceuticals. These initiatives are aimed at improving access to medicines, enhancing national health security, and reducing reliance on imported medical supplies.
President Dr Mohamed Irfaan Ali has repeatedly identified healthcare and medicine as central pillars of his Vision 2030 development agenda, emphasising the need to build domestic capability not only in the delivery of advanced medical services but also in the storage, supply, and potential production of essential medicines. The administration has underscored that modern infrastructure, and internationally aligned standards, will be critical to achieving these goals.
Private-sector participation is expected to complement the Government’s multi-billion-dollar investments in expanding hospital networks, introducing specialised services, and advancing pharmaceutical manufacturing capacity. Officials believe these combined efforts will help create a more resilient and self-sustaining national health system.
Beyond improvements in healthcare delivery, authorities view investment in the sector as a driver of wider economic transformation. Expanded pharmaceutical and medical industries are expected to generate skilled employment, encourage technology transfer, and support Guyana’s transition toward higher-value economic activity.
Senior Minister within the Office of the President with responsibility for Finance, Dr Ashni Singh, has previously stressed that diversification into health-related industries forms a key component of the Government’s strategy to ensure balanced and sustainable growth alongside continued oil and gas expansion. Investments that strengthen human capital and social infrastructure, he has noted, are essential to converting economic growth into long-term national development.
Officials say engagements with companies such as Royal Group reflect Guyana’s broader strategy of attracting responsible international partners whose investments align with national priorities, promote job creation, and contribute to building a more diversified and resilient economy.
Ramsaroop was accompanied at the meeting by Director of Economic Affairs Arvinda Ramcharan and Foreign Service Officer at the Ministry of Foreign Affairs and International Cooperation Natala Anderson.
